Does ELRANATAMAB-BCMM Cause Decreased appetite? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Decreased appetite have been filed in association with ELRANATAMAB-BCMM. This represents 3.0% of all adverse event reports for ELRANATAMAB-BCMM.
17
Reports of Decreased appetite with ELRANATAMAB-BCMM
3.0%
of all ELRANATAMAB-BCMM reports
2
Deaths
10
Hospitalizations
How Dangerous Is Decreased appetite From ELRANATAMAB-BCMM?
Of the 17 reports, 2 (11.8%) resulted in death, 10 (58.8%) required hospitalization, and 2 (11.8%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELRANATAMAB-BCMM. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does ELRANATAMAB-BCMM Cause?
Cytokine release syndrome (115)
Death (51)
Pyrexia (46)
Fatigue (31)
Neoplasm progression (31)
Cytomegalovirus infection reactivation (29)
Malignant neoplasm progression (27)
Off label use (27)
Immune effector cell-associated neurotoxicity syndrome (26)
Infection (25)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which ELRANATAMAB-BCMM Alternatives Have Lower Decreased appetite Risk?
ELRANATAMAB-BCMM vs ELTROMBOPAG
ELRANATAMAB-BCMM vs ELTROMBOPAG OLAMINE
ELRANATAMAB-BCMM vs ELUXADOLINE
ELRANATAMAB-BCMM vs ELVITEGRAVIR
ELRANATAMAB-BCMM vs EMAPALUMAB